Candriam SCA’s Veradigm Inc. Common Stock MDRX Stock Holding History

Candriam SCA’s Portfolio MDRX Stock Details MDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-33,580	Closed	-$403K	–	891
2023 Q1	$403K	Buy	+33,580	New	+$544K	﹤0.01%	823
2020 Q4	–	Sell	-170,000	Closed	-$1.38M	–	853
2020 Q3	$1.38M	Buy	170,000 +95,000	+127%	+$776K	0.01%	556
2020 Q2	$508K	Hold	75,000	–	–	0.01%	704
2020 Q1	$720K	Hold	75,000	–	–	0.01%	682
2019 Q4	$736K	Hold	75,000	–	–	0.01%	699
2019 Q3	$824K	Hold	75,000	–	–	0.01%	638
2019 Q2	$868K	Buy	75,000 +40,000	+114%	+$407K	0.01%	678
2019 Q1	$334K	Hold	35,000	–	–	﹤0.01%	755
2018 Q4	$337K	Hold	35,000	–	–	0.01%	736
2018 Q3	$499K	Sell	35,000 -160,000	-82%	-$2.17M	0.01%	709
2018 Q2	$2.34M	Hold	195,000	–	–	0.04%	457
2018 Q1	$2.41M	Hold	195,000	–	–	0.04%	436
2017 Q4	$2.84M	Buy	195,000 +60,000	+44%	+$833K	0.05%	388
2017 Q3	$1.92M	Buy	135,000 +30,000	+29%	+$388K	0.03%	466
2017 Q2	$1.34M	Hold	105,000	–	–	0.03%	533
2017 Q1	$1.33M	Hold	105,000	–	–	0.03%	520
2016 Q4	$1.07M	Hold	105,000	–	–	0.02%	505
2016 Q3	$1.38M	Buy	+105,000	New	+$1.4M	0.03%	434

Other funds holding MDRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Candriam SCA's MDRX Position: Q2 2023 in Review

Candriam SCA sold out of Veradigm Inc. Common Stock (MDRX) in Q2 2023, closing a stake of 33,580 shares — an estimated $403K sold.

Candriam SCA first reported a position in MDRX in Q3 2016 and held it in 18 quarters. The position peaked at $2.84M in Q4 2017. 229 funds tracked by Wall St. Rank hold MDRX as of Q2 2023.

Candriam SCA reported no remaining Veradigm Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Candriam SCA sold 33,580 Veradigm Inc. Common Stock shares in Q2 2023, an estimated $403K.
Candriam SCA first reported a position in Veradigm Inc. Common Stock in Q3 2016 and held it in 18 quarters.
Candriam SCA's Veradigm Inc. Common Stock position peaked at $2.84M in Q4 2017.
229 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q2 2023.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.